- Home
- DLHC vs RENB Comparison
DLHC vs RENB Comparison
Compare DLHC & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLHC
- RENB
- Stock Information
- Founded
- DLHC 1969
- RENB 2011
- Country
- DLHC United States
- RENB United States
- Employees
- DLHC N/A
- RENB N/A
- Industry
- DLHC Business Services
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- DLHC Consumer Discretionary
- RENB Health Care
- Exchange
- DLHC Nasdaq
- RENB Nasdaq
- Market Cap
- DLHC 59.7M
- RENB 56.2M
- IPO Year
- DLHC N/A
- RENB N/A
- Fundamental
- Price
- DLHC $5.00
- RENB $0.31
- Analyst Decision
- DLHC
- RENB
- Analyst Count
- DLHC 0
- RENB 0
- Target Price
- DLHC N/A
- RENB N/A
- AVG Volume (30 Days)
- DLHC 48.1K
- RENB 1.6M
- Earning Date
- DLHC 05-07-2025
- RENB 05-15-2025
- Dividend Yield
- DLHC N/A
- RENB N/A
- EPS Growth
- DLHC 75.08
- RENB N/A
- EPS
- DLHC 0.38
- RENB N/A
- Revenue
- DLHC $377,074,000.00
- RENB N/A
- Revenue This Year
- DLHC N/A
- RENB N/A
- Revenue Next Year
- DLHC N/A
- RENB N/A
- P/E Ratio
- DLHC $13.32
- RENB N/A
- Revenue Growth
- DLHC N/A
- RENB N/A
- 52 Week Low
- DLHC $2.72
- RENB $0.28
- 52 Week High
- DLHC $12.23
- RENB $2.34
- Technical
- Relative Strength Index (RSI)
- DLHC 65.31
- RENB 40.81
- Support Level
- DLHC $4.95
- RENB $0.30
- Resistance Level
- DLHC $5.13
- RENB $0.34
- Average True Range (ATR)
- DLHC 0.23
- RENB 0.05
- MACD
- DLHC 0.02
- RENB 0.01
- Stochastic Oscillator
- DLHC 81.44
- RENB 12.30
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.